| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 2,108,000 | 1,866,000 | 1,693,000 | 2,048,400 | | Cost of Revenue | 1,771,000 | 1,629,000 | 1,548,000 | 1,883,600 | | | Gross Profit | 337,000 | 237,000 | 145,000 | 164,800 | | | Operating Expenses | | Research Development | 36,000 | 36,000 | 36,000 | 35,700 | | Selling General and Administrative | 214,000 | 199,000 | 189,000 | 220,500 | | Non Recurring | 62,000 | 63,000 | 14,000 | 27,400 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 25,000 | (61,000) | (94,000) | (118,800) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (4,000) | 831,000 | (4,000) | 802,800 | | Earnings Before Interest And Taxes | (179,000) | 833,000 | (159,000) | 688,400 | | Interest Expense | (113,000) | 113,000 |
-
| 64,500 | | Income Before Tax | (66,000) | 720,000 | (159,000) | 623,900 | | Income Tax Expense |
-
| 311,000 | 138,000 | 147,700 | | Minority Interest |
-
|
-
| 4,000 | 6,000 | | | | Net Income From Continuing Ops | (66,000) | 409,000 | (297,000) | 482,200 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| 3,000 | 112,400 | | Extraordinary Items |
-
|
-
|
-
| 3,600 | | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (64,000) | 402,000 | (290,000) | 598,200 | | Preferred Stock And Other Adjustments | (4,000) | 4,000 |
-
|
-
| | | Net Income Applicable To Common Shares | ($68,000) | $406,000 | ($290,000) | $598,200 |
|
0.22% Nasdaq 
Income Statement
